Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 09 May 2024 08:22:03 +0200Fri, 26 Apr 2024 17:54:00 +0200Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 8, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/prevenar-20-previously-apexxnarHuman medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 8, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/prevenar-20-previously-apexxnarFri, 26 Apr 2024 17:54:00 +0200Human medicinePrevenar 20 (previously Apexxnar) : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5451-en.pdfPrevenar 20 (previously Apexxnar) : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5451-en.pdfTue, 12 Mar 2024 11:35:00 +0100Human medicine